SMS Lifesciences India Limited

NSEI:SMSLIFE Rapporto sulle azioni

Cap. di mercato: ₹4.4b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

SMS Lifesciences India Performance dei guadagni passati

Il passato criteri di controllo 4/6

Gli utili di SMS Lifesciences India sono diminuiti a un tasso medio annuo di -4.6%, mentre il settore Pharmaceuticals ha visto gli utili crescere a un tasso medio annuo di 15.4%. I ricavi sono cresciuti crescere a un tasso medio annuo di 0.5%. Il ritorno sul capitale proprio di SMS Lifesciences India è 8.9% e ha margini netti di 5.5%.

Informazioni chiave

-4.6%

Tasso di crescita degli utili

-4.6%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore17.5%
Tasso di crescita dei ricavi0.5%
Rendimento del capitale proprio8.9%
Margine netto5.5%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Aug 01
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Jun 13
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

Feb 10
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Jan 05
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

Sep 23
Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

Sep 07
SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

Aug 24
SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 16
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 02
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

Jun 03
SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

May 13
With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Nov 23
SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Jun 21
Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Feb 22
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 04
SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Nov 27
Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Nov 24
Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Ripartizione dei ricavi e delle spese

Come SMS Lifesciences India guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NSEI:SMSLIFE Ricavi, spese e utili (INR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 243,2391795120
31 Mar 243,060914970
31 Dec 232,797494860
30 Sep 233,121464750
30 Jun 233,079674480
31 Mar 233,1561154400
31 Dec 223,4751894270
30 Sep 223,5051724210
30 Jun 223,5582474140
31 Mar 223,5012534010
31 Dec 213,3662133810
30 Sep 213,1182163510
30 Jun 212,8711473340
31 Mar 212,6561363080
31 Dec 202,2911062900
30 Sep 202,091762710
30 Jun 202,237792650
31 Mar 202,6081022670
31 Dec 193,2201272640
30 Sep 193,9701882720
30 Jun 194,0981952410
31 Mar 193,7791782360
31 Dec 182,9971462040
30 Sep 182,6971191940
30 Jun 182,315851860
31 Mar 182,130651790
31 Dec 172,148721790
30 Jun 172,034901800
31 Mar 172,1591291710

Guadagni di qualità: SMSLIFE ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di SMSLIFE (5.5%) SMSLIFE sono più alti rispetto allo scorso anno (2.2%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di SMSLIFE sono diminuiti del 4.6% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di SMSLIFE nell'ultimo anno ( 168.6% ) supera la media quinquennale ( -4.6% all'anno).

Guadagni vs Settore: La crescita degli utili SMSLIFE nell'ultimo anno ( 168.6% ) ha superato la percentuale del settore Pharmaceuticals 19.3%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 8.9% ) di SMSLIFE è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate